Who owns Generex Biotechnology Corporation?

Key details on Generex Biotechnology Corporation (Ticker: GNBT)

Who owns Generex Biotechnology Corporation?

Is GNBT a good stock to own? Find out who bought Generex Biotechnology Corporation, who sold Generex Biotechnology Corporation (GNBT) stock, and who holds a large position in Generex Biotechnology Corporation.

Fund Name Number of Shares Share Valuation As Of
United Capital Financial Advisers 184000 $27600 Dec. 31, 2011
Janney Montgomery Scott 54400 $1022 Sept. 30, 2014
Oxbow Advisors 10400 $0 Sept. 30, 2013
Herndon Plant Oakley 10400 $1040 Sept. 30, 2012
Addison Capital 10000 $0 March 31, 2014
Argyle Capital Management 10000 $0 Dec. 31, 2013
E E Geduld 10000 $1000 June 30, 2012

Who sold Generex Biotechnology Corporation?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ameriprise Financial March 31, 2011 6500 $975
Bascom Hill Partners Dec. 31, 2010 60000 $397200
SummitAlliance Capital Management Dec. 31, 2010 29950 $8985
Tradeworx March 31, 2010 231131 $124810
Zebra Capital Management Dec. 31, 2007 4800 $8016